Physician profile
Eugene M Parent
NPI 1437135621
$301,619.13
in general payments reported to CMS, 2019-2025
37 companies · $8,015 in 2025
The $8,015 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $33K · 2021: $51K · 2022: $52K · 2023: $41K · 2024: $39K · 2025: $8,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Consulting Fee: $8,500 · Food and Beverage: $7,746 · Travel and Lodging: $5,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $66,426.60 |
| Consulting Fee | $8,500.00 |
| Food and Beverage | $7,745.82 |
| Travel and Lodging | $5,841.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $108,940.44 | 2019-2025 | Jardiance |
| Abbott Laboratories | $85,987.13 | 2019-2025 | Mitraclip, Amplatzer Talisman, Triclip |
| Lilly USA, LLC | $71,295.86 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $30,300.33 | 2019-2025 | Watchman Access System, Watchman Flx, General - Brady |
| Edwards Lifesciences Corporation | $1,277.00 | 2024-2025 | Evoque, Pascal |
| Medtronic Vascular, INC. | $895.13 | 2019 | |
| Cvrx, INC. | $452.04 | 2023-2025 | Barostim Neo System |
| Inari Medical, INC. | $323.60 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $309.83 | 2024-2025 | Amvuttra, Onpattro |
| Heartflow, INC. | $222.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $220.84 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $138.82 | 2019-2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $137.88 | 2019 | |
| Abiomed | $120.91 | 2023 | Impella |
| Pfizer INC. | $113.18 | 2019-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $112.40 | 2023 | Indigo System |
| Amgen INC. | $96.61 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $93.38 | 2021-2024 | Xarelto |
| Philips North America LLC | $92.92 | 2022-2024 | (Ck4) Mcot |
| Novo Nordisk INC | $67.09 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Biosense Webster, INC. | $52.02 | 2022-2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $44.98 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.09 | 2019-2022 | |
| Medtronic, INC. | $39.23 | 2023 | Mycarelink |
| Biotronik INC. | $24.98 | 2020 | |
| Preventice Services, LLC | $24.92 | 2021 | |
| Arineta, INC | $24.42 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $23.35 | 2019 | |
| Amarin Pharma, INC. | $19.96 | 2020 | |
| Irhythm Technologies, INC. | $18.25 | 2024 | Zio Monitor, Zio Xt Patch |
| Medicomp INC | $17.17 | 2019 | |
| Esperion Therapeutics, INC. | $16.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.76 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $15.38 | 2019 | |
| Ge Healthcare | $15.25 | 2021 | |
| Stryker Corporation | $13.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Parent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.